Some genes in ER-associated co-expressed networks alter the gene expression profile of luminal breast cancer cells and are predictive of patient response to breast cancer therapy (Tozlu et al., 2006; Chen et al., 2011; Zhu et al., 2020). The gene discussed is ESR1; the disease is breast carcinoma.